Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gallium phytate Ga 67 is a radiopharmaceutical agent in which the radioisotope gallium-67 is chelated with phytate (inositol hexaphosphate). It is used primarily as a diagnostic imaging agent in nuclear medicine. The compound accumulates in areas of altered reticuloendothelial activity, such as the liver and spleen, and can be used for scintigraphic evaluation of hepatic function or to assess reticuloendothelial system disorders. Its mechanism involves localization via phagocytosis by Kupffer cells and other components of the mononuclear phagocyte system. Gallium-67 emits gamma radiation suitable for detection by gamma cameras.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gallium phytate Ga 67.